IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma

Van Der Weyden, C; Bagot, M; Neeson, P; Darcy, PK; Prince, HM

Prince, HM (reprint author), Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018; 27 (8): 691

Abstract

Introduction: Therapeutic options for mycosis fungoides and Sezary syndrome include a variety of immunomodulatory, epigenetic, and cytotoxic options; ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索